Equities

Pharma Foods International Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Pharma Foods International Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)632.00
  • Today's Change-21.00 / -3.22%
  • Shares traded311.70k
  • 1 Year change-33.47%
  • Beta1.4597
Data delayed at least 15 minutes, as of Feb 17 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Pharma Foods International Co Ltd had net income fall -88.52% from 3.21bn to 368.00m despite a 5.01% increase in revenues from 62.15bn to 65.26bn. An increase in the selling, general and administrative costs as a percentage of sales from 68.48% to 74.72% was a component in the falling net income despite rising revenues.
Gross margin80.32%
Net profit margin-2.84%
Operating margin-1.72%
Return on assets-5.74%
Return on equity-18.06%
Return on investment-16.01%
More ▼

Cash flow in JPYView more

In 2025, cash reserves at Pharma Foods International Co Ltd fell by 6.51bn. Cash Flow from Investing was negative at 950.00m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 1.09bn for operations while cash used for financing totalled 4.47bn.
Cash flow per share-38.42
Price/Cash flow per share--
Book value per share324.90
Tangible book value per share321.06
More ▼

Balance sheet in JPYView more

Pharma Foods International Co Ltd has a Debt to Total Capital ratio of 61.51%, a higher figure than the previous year's 9.50%.
Current ratio1.03
Quick ratio0.6512
Total debt/total equity1.60
Total debt/total capital0.6151
More ▼

Growth rates in JPY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -88.64%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)1.40%
Div growth rate (5 year)24.08%
Payout ratio (TTM)--
EPS growth(5 years)-11.65
EPS (TTM) vs
TTM 1 year ago
-155.84
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.